| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 11.135 | 10.922 | 28.105 | 24.513 | 26.171 | 19.803 | 25.170 | 25.390 | 31.224 | 38.170 |
| Total Income - EUR | 11.135 | 10.922 | 28.105 | 27.517 | 26.171 | 19.803 | 25.170 | 25.390 | 31.224 | 38.170 |
| Total Expenses - EUR | 9.863 | 8.543 | 13.779 | 5.412 | 9.651 | 9.163 | 11.106 | 6.745 | 7.811 | 12.808 |
| Gross Profit/Loss - EUR | 1.272 | 2.379 | 14.326 | 22.105 | 16.520 | 10.640 | 14.064 | 18.645 | 23.413 | 25.362 |
| Net Profit/Loss - EUR | 938 | 2.052 | 13.482 | 21.280 | 15.735 | 10.053 | 13.445 | 17.883 | 20.229 | 21.386 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Tano Medica S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 4.788 | 24.870 | 17.119 | 16.790 | 13.682 | 10.693 | 7.462 | 5.578 | 2.730 | 121 |
| Current Assets | 395 | 796 | 1.354 | 17.860 | 2.404 | 199 | 6.908 | 12.636 | 24.912 | 22.077 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 43 | 0 | 0 | 0 | 10.776 | 0 | 17.016 |
| Cash | 395 | 796 | 1.354 | 17.817 | 2.404 | 199 | 6.908 | 1.860 | 24.912 | 5.061 |
| Shareholders Funds | -2.194 | -120 | 13.364 | 34.398 | 15.786 | 10.103 | 13.493 | 17.931 | 27.363 | 21.434 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 7.377 | 25.785 | 5.109 | 252 | 301 | 790 | 877 | 283 | 280 | 764 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Tano Medica S.r.l.